Pharmacological treatments address hormonal and metabolic derangements: metformin remains a cornerstone for insulin resistance and hyperinsulinemia, both improving ovulation and indirectly reducing insulin-induced ROS production [159]. The gene discussed is INS; the disease is Hyperinsulinemia.